Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FSHD6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,140
Award facts
- Contract value 100% obligated
- $13,139.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,139.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The award, issued on January 26, 2026, with an ultimate completion date of February 17, 2026, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal military medical supply chain, with demonstrated performance across multiple therapeutic categories including oncology treatments, biologics, vaccines, and specialty pharmaceuticals. The contractor's registration in the System for Award Management dates to July 2001, and recent contracting activity through the Defense Logistics Agency's Medical Supply Chain division reflects consistent performance on numerous delivery orders ranging from under $100 to over $115,000. As a prime vendor under the PPV-G GEN V program through December 31, 2036, DMS Pharmaceutical Group is positioned to support recurring pharmaceutical requirements for military healthcare operations globally through firm fixed-price delivery orders issued by the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FSHD6?
SPE2DR26FSHD6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FSHD6 worth?
The government has obligated $13,140 on SPE2DR26FSHD6.
Is contract SPE2DR26FSHD6 an order under another contract?
Yes. SPE2DR26FSHD6 is a delivery order under SPE2DR25D9305, an indefinite delivery contract.
Was contract SPE2DR26FSHD6 competed?
The extent of competition for SPE2DR26FSHD6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award